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Abstract
Patch-clamp recordings in a whole-cell mode were performed on dorsal sensory cells enzymatically isolated
from the spinal cord of two lamprey species, Ichthyomyzon unicuspis and Lampetra fluviatilis. The voltageactivated currents through calcium channels were analysed. GABA and the specific GABAB receptor
agonist baclofen reduced the peak amplitude of inward Ba2+ current, as a robust alternate charge carrier
through voltage-dependent Ca2+ channels. These effects were dose-dependent and reversible. GABAB receptor
antagonists, 2-hydroxysaclofen and δ-amino-n-valeric acid, blocked the reduction of Ba2+ currents by GABA and
baclofen, while bicuculline, a GABAA receptor antagonist, had no blocking action. GABA and baclofen did not
modify the dorsal sensory cell membrane conductance, indicating that they did not activate ligand-gated
channels. However, GABA, but not baclofen, considerably increased membrane conductance and induced
Cl− currents in isolated multipolar neurons (presumably interneurons and/or motoneurons). These findings
suggest that GABA and baclofen action on lamprey dorsal sensory cells is mediated by GABAB receptors. We
concluded that GABA-mediated presynaptic inhibition of lamprey dorsal sensory cell fibers results from
GABAB receptor activation followed by a decrease of inward voltage-activated calcium currents. Appositions of
GABA-immunoreactive boutons to horseradish peroxidase-labelled fibers from the dorsal root were observed at
the ultrastructural level in the dorsal column using postembedding immunogold cytochemistry. It seems likely
that these appositions represent the morphological substrate of dorsal sensory cell fiber presynaptic inhibition.
In very rare cases, ultrastructural features were observed which could be interpreted as synaptic specializations
between the GABA-immunoreactive boutons and the primary afferent fibers.
The extrasynaptic action of GABA as a basis of presynaptic inhibition of this population of primary afferent
neurons is discussed.
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Presynaptic inhibition plays an important role in the coordinating mechanisms of the spinal cord. It has been
studied in detail in primary afferent fibers of the mammalian spinal cord, and its main features consist of (i)
depression of the synaptic response of the postsynaptic neuron without modifying its membrane electrical
parameters, (ii) primary afferent depolarization, and (iii) axoaxonal contacts with GABA used as a
neurotransmitter.14, 29, 30, 45Presynaptic inhibition has also been found in the central nervous systems of
invertebrates[25]and of several non-mammalian vertebrate groups: cyclostomes,[5]amphibians,34, 64and
reptiles,[61]thus indicating the widespread character of this phenomenon.
Two mechanisms have been considered as the possible basis for GABA-mediated presynaptic inhibition.
According to the first mechanism, presynaptic inhibition is the result of primary afferent depolarization
produced by GABA.21, 29, 45, 58In this case, the action potential amplitude decreases as a result of membrane
resistance shunting following Cl− current activation induced by GABA action on GABAA receptors.[3]A second
mechanism has been proposed recently. It has been shown that GABA application reduces voltage-dependent
Ca2+ current through the nerve cell membrane.23, 26, 47In this case, the GABA effect is mediated by activation
of GABAB receptors of the presynaptic neuron membrane. Activation of GABAB receptors reduces
Ca2+ presynaptic influx and thereby decreases transmitter release from the presynaptic
neuron.11, 13, 15, 28, 35, 39, 43, 46
Physiological studies of presynaptic inhibition in the lamprey have shown that it is an important component of
the lamprey spinal cord locomotor system.3, 4, 5In the spinal cord in vitro preparation, GABA modified the
frequency of ventral root motor bursts during fictive swimming without changing the electrical parameters of
the motoneurons, and these effects persisted in the presence of bicuculline, a GABAA receptor antagonist.[5]It
has been concluded that in the lamprey spinal cord, GABA-mediated presynaptic inhibition occurs both in
interneuron axons[3]and in primary afferent fibers.[17]GABA and the GABAB receptor agonist reduced the
monosynaptic excitatory postsynaptic potentials (EPSPs) produced in spinal interneurons by primary afferent
neuron stimulation. Baclofen alone or GABA in the presence of bicuculline did not alter the input resistance or
membrane potential of the postsynaptic neurons.[17]More recently, Matsushima et al.[47]demonstrated using
single-electrode current-clamp and voltage-clamp that baclofen reduced the peak amplitude of Ca2+ (Ba2+)
currents in lamprey spinal motoneurons and interneurons. However, direct analysis of GABAergic actions on the
ionic currents of primary sensory neurons has been lacking.
Several studies have investigated the morphological substrates of primary afferent presynaptic inhibition in the
lamprey. GABA-immunopositive terminals apposed to labelled axons of different functional properties have
been demonstrated using light microscopy.[16]GABA-immunopositive terminals apposed to unlabelled fibers
located in the dorsal columns and in the ventrolateral aspect of the spinal cord have also been observed using
an ultrastructural analysis.[20]Recently, we have demonstrated that GABA-immunopositive cells are
concentrated in the dorsal part of the lamprey spinal cord in the vicinity of primary afferent neurons, called
dorsal sensory cells (DSCs), and their fibers.[8]
In the present work, we have obtained additional evidence concerning the ionic mechanisms and the
morphological substrates of presynaptic inhibition in the lamprey spinal cord. Physiologically, we have
demonstrated that GABA and baclofen modulate Ba2+ current in DSCs and that GABAB receptor antagonists
eliminate this effect. Morphologically using immunogold and horseradish peroxidase (HRP) methods, we have

demonstrated that GABA-immunoreactive boutons make appositions to HRP-labelled fibers from the dorsal
roots. Preliminary results have been reported previously.66, 67

1. Experimental procedures
1.1. Physiological investigations
Patch-clamp recordings in a whole-cell mode were performed on DSCs from the spinal cord of two lamprey
species, Ichthyomyzon unicuspis (30–36 cm long) and Lampetra fluviatilis (29–33 cm long). Prior to the
experiments, the animals were maintained in the laboratory in well-aerated tanks (5–10°C). After anesthesia by
immersion of the lamprey in tricaine, 3–4 cm lengths of spinal cord were removed and cut into 1–1.5-mm-long
pieces. Individual cells were isolated by gentle trituration of these pieces of spinal cord after pretreatment with
collagenase (1.6 mg/ml) and pronase (0.5 mg/ml). All procedures have been previously described in
detail.[9]After dissociation, the cells were stored in a larger part of the recording chamber mounted on the stage
of an inverted microscope (BIOLAM-1, LOMO, Russia). This larger part had a volume of 2 ml, and the volume of a
well-isolated smaller part used for recordings was 0.5 ml. Solution N° 1, used for cell storage, consisted of the
following (in mM): NaCl 92.0, KCl 2.5, CaCl2 2.6, MgCl2 2.4, HEPES (Na-salt) 20.0, EGTA 0.3, NaHCO3 3.0,
NaH2PO4 0.75, Na2HPO4 0.25, glucose 10.0, pH 7.4. Solution N° 2, used for recording calcium channel currents,
consisted of the following (in mM): BaCl2 60.0, tetraethylammonium (TEA)-Cl 40.5, EGTA 0.1, MgCl2 2.4, HEPES
15.0, tetrodotoxin (TTX) 0.001, pH 7.3. Both solutions were aerated with O2 and kept cooled (10°C). Isolated
DSCs could be clearly distinguished by their morphological features: they were bipolar cells with a round-shaped
soma with a diameter of 35–60 μm and one or two branches from 30 up to 200 μm length. Pipettes having tip
diameters of 2–3 μm and resistances of 2–5 MOhms were pulled from Micro-Haematocrit capillary tubes
(Labcraft Brand). The intrapipette solution consisted of the following (in mM): Cs-glutamate 100.0,
CsMeSO4 20.0, MgCl2 4.0, TEA-acetate 8.0, HEPES 10.0, EGTA 8.5, ATP 5.0, GTP 1.0, creatine phosphate (CP)
14.0, CP kinase 50 U/ml, leupeptin 0.01, glucose 10.0, pH 7.3. For a whole-cell recording the classical pressure
rupture of the membrane inside the pipette and the equilibration of the intrapipette solution with the
cytoplasm was used. After obtaining a whole-cell recording, the membrane potential was voltage-clamped at
−60 mV. The pipette with the attached cell was then moved to the smaller part of the recording chamber.
Voltage-dependent inward current was evoked by a series of depolarizations from holding potentials of −60 or
−80 mV up to +30 mV using 10 mV steps of 500 ms duration. Macroscopic currents through calcium channels
were isolated from voltage-dependent sodium and potassium channel currents as described by others.36, 48It is
known that Ba2+ ions pass through the calcium channels and Ba2+ was used here as a charge carrier to provide a
large, stable current and to remove Ca2+-dependent effects due to changes in intracellular Ca2+ concentration.
This approach is widely used for isolating calcium channel currents.[10]Drugs were applied to within 200 μm of
the neuron using a Hamilton microsyringe. Whole-cell recordings were performed using the AXOPATCH-1D
amplifier (Axon Instruments, U.S.A.) with the CV-4 headstage (Axon Instruments). The recordings were digitized
with a DigiData-1200 (Axon Instruments) and stored on the hard disk of the computer IBM-PC-486. The program
CLAMPEX of the pCLAMP 6.2 software package was used for data acquisition. For data analysis, the CLAMPFIT
program of the same package was used. Leakage currents and capacitative currents were not subtracted.
Membrane conductance was evaluated from the transmembrane current changes in response to a series of
small voltage steps applied to the cell.

1.2. Morphological investigations
Six adult lampreys Lampetra fluviatilis 29–33-cm-long were used for postembedding immunogold cytochemistry
with GABA antibodies. After anesthesia by immersion in tricaine, a 5–6 segment length of spinal cord from the
dorsal fin region was dissected in aerated (98% O2+2% CO2) physiological solution consisting of the following (in
mM): 115 NaCl, 0.8 NaH2PO4, 0.2 Na2HPO4, 2.0 KCl, 2.0 CaCl2, 0.9 MgCl2, 8.0 NaHCO3, 5.5 glucose, pH 7.3–7.4.

HRP (Boehringer) was applied to the central stump of a cut dorsal root from a suction pipette using
iontophoresis. The pipette contained a 5–10% solution of HRP in 0.1 M phosphate buffer, pH 8.4. Positive
current (3–5 nA) was applied to the pipette during the first 0.5 h, then the spinal cord piece was allowed to
survive for 10–24 h with the HRP pipette remaining in place. The spinal cord piece was then fixed for 3–4 h with
1% paraformaldehyde and 2.5% glutaraldehyde in 0.1 M phosphate buffer, pH 7.4. The spinal cord piece was
processed for HRP with the Adams' technique,[1]cut into 2-mm-long pieces and Epon-embedded for
conventional electron microscopy. Ultrathin sections were mounted on nickel grids and processed according to
the standard immunogold procedure using polyclonal anti-GABA antisera, raised in rabbit (Immunotech) and
diluted 1:2 000 in Tris-buffered saline (pH 7.6) and goat anti-rabbit immunoglobulin coupled to colloidal gold
particles, mean diameter 15 nm (Janssen) and diluted 1:75. Profiles were considered to be immunopositive if the
density of gold particles exceeded that of the surrounding tissue by five-fold.
Control sections of lamprey spinal cord tissue, were reacted with fixative in the presence of GABA, l-glutamate,
glycine, taurine, or l-aspartate, as described by Ottersen,[53]and then incubated with the anti-GABA antiserum.
A high specificity of antiserum has been observed in most tests, though a weak cross-reactivity was found when
the GABA antibody was used in the aspartate immunoconjugate. Another control test consisted of omitting the
first antibody, which resulted in no labelling.
To evaluate the size and shape of synaptic vesicles, their diameters were measured and an index of vesicle
ellipticity, e, was calculated according to the equation
𝑒 = 𝑎2 − 𝑏 2 𝑎
where a and b represent the longest and shortest diameters of the synaptic vesicles, respectively (0≤e<1, for
round-shaped vesicles e=0).[50]Values throughout the text are presented as mean±S.E.M.

1.3. Materials
δ-Amino-n-valeric acid (AVA), l-aspartate, baclofen, (−)bicuculline methiodide, GABA, glycine, l-glutamate,
muscimol, taurine, TEA, tricaine (MS 222), and TTX were obtained from Sigma Chemical Co., St. Louis, MO, U.S.A.
2-Hydroxysaclofen was obtained from Research Biochemicals International, Natick, MA, U.S.A.

2. Results
Fig. 1 is a schematic drawing of lamprey spinal cord sensory input. Primary afferent neurons of the lamprey
spinal cord consist of two populations. One of them, as in other vertebrates, is the spinal ganglion cells, and the
second consists of the DSCs which have a large soma (30–60 μm) located in the dorsal part of the spinal cord just
below the dorsal fiber column. The DSCs are homologous to the Rohon-Beard cells of fish and
amphibians.19, 32, 52, 57The dorsal roots are composed of both the central branches of the dorsal root
ganglion cells and the peripheral branches of the DSCs. Ascending and descending axons of primary afferent
neurons are located in the dorsal fiber column.

Fig. 1. Schematic drawing of a lamprey spinal cord segment illustrating some connections of two types of
primary afferent neurons: dorsal sensory cells and dorsal root ganglion cells.

2.1. Physiological investigations
After dissociation, DSCs having processes from 40 to 200 μm in length were chosen for investigation. The
currents through the calcium channels were recorded in more than 200 DSCs and analysed in 59 DSCs
of Ichthyomyzon unicuspis and in 44 DSCs of Lampetra fluviatilis. These cells had membrane potentials from −32
to −60 mV (mean=−40.5±9.1 mV) and generated Na+ and K+ currents with amplitudes up to 50 nA in the normal
solution (N° 1), when applying depolarizing voltage steps from the holding potential −100 mV up to +30 mV in a
voltage-clamp mode (Fig. 2A, B). After performing this test to evaluate the condition of the cell, the pipette with
the cell attached was then moved to the smaller part of the recording chamber, and the normal solution (N° 1)
was replaced by the calcium current solution (N° 2). After 2–3 min exposure to solution N° 2, a series of
depolarizing steps from −100 up to +40 mV evoked inward currents with kinetic parameters different than the
Na+ and K+ currents recorded in the normal solution (Fig. 2C). Based on the current–voltage relationship, this
current is likely to be a calcium channel current carried by Ba2+. The amplitude of the current was stable during
>30 min perfusion with 1 μM TTX, and it was blocked by the addition of 5 mM CdCl2 (Fig. 2D). It was the barium
current in this case because Ca2+ was replaced with Ba2+ in the bath solution. Those cells maintaining stable
parameters of Ba2+ current throughout the recording period were chosen for further analysis. The Ba2+ currents
in DSCs from the two lamprey species used had similar values (see Table 1).

Fig. 2. Voltage-activated currents in an isolated dorsal sensory cell. Shifting the potential from −100 mV up to
+30 mV produced Na+ and K+ currents through the membrane in solution No 1 containing Na+ and K+ ions (A).
The corresponding current–voltage curve is shown in B for the peak inward currents. When the same cell was
bathed in solution No 2 containing no Na+ and K+ ions and with Ba2+ replacing Ca2+, shifting the potential from
−100 mV up to +40 mV produced an inward current through the calcium channels (C). In (D) the current–voltage
curves for the currents in (C) are given before (round dots) and after block of the Ba2+ current by 5 mM
Cd2+ (square dots).
Table 1. Parameters of the barium current in dorsal sensory cells of two lamprey species
Species
Ichthyomyzon unicuspis
Lampetra fluviatilis

Threshold potential of
Ba2+ current
−35 to +5 mV
−30 to −10 mV

Potential of peak
Ba2+ current
−8 to +30 mV
−20 to +10 mV

Mean peak value of
Ba2+ current
7.24±3.6 nA (n=59)
8.48±6.0 nA (n=44)

Addition of GABA to the perfusion solution always reduced the Ba2+ current amplitude. A typical effect of GABA
on the Ba2+ current is illustrated in Fig. 3A. The GABA effect was dose-dependent and reversible. The minimal
concentration of GABA required was 0.1 mM, while 10 mM GABA reduced the Ba2+ current by 50%. We typically
used moderate concentrations of GABA (1 and 4 mM) which permitted repeating the effect with serial reapplications and washes. The peak reduction of the Ba2+ current by GABA occurred within 1–2 min, and,
therefore, all measurements of GABA effects were made 2 min after the addition of GABA. Application of 4 mM
GABA reduced the peak current amplitude by a mean value of 28.5±4.9% (n=45). After 2 min washing in GABAfree solution, the peak current amplitude recovered to 96.2±9.2% in both species (n=45). GABA application did
not change membrane conductance, nor did it cause opening of Cl− channels (see below).
Baclofen, a selective GABAB receptor agonist, mimicked the GABA effect on the Ba2+ current in DSCs of both
species (Fig. 3B). After 2 min perfusion with solution N° 2 containing 0.5 mM baclofen, the peak amplitude of the
Ba2+ current was reduced by 25.5%±3.8% (n=30). After subsequent 2 min perfusion with baclofen-free solution,
the Ba2+ current recovered its initial level (Fig. 3B).

Fig. 3. Action of GABA and baclofen on the voltage-activated Ba2+ currents in an isolated dorsal sensory cell.
Application of 4 mM GABA (A) and 0.5 mM baclofen (B) to the bath solution reduced the peak amplitude of the
voltage-activated Ba2+ currents by 28.5% and 25.5%, respectively. After 2 min of wash out, the currents
recovered 96.2% (A) and 89.1% (B) of their control levels.
To determine the pharmacological properties of the receptors activated by GABA and baclofen in DSCs
membranes, specific antagonists of GABAA and GABAB receptors were used. In all seven DSCs tested, the GABA
effect was not modified by a prior 1 min exposure of the cell to 0.1 mM bicuculline, a GABAA receptor antagonist
(Fig. 4A,B). Similarly, in two DSCs, it was examined whether bicuculline antagonized the action of baclofen. The

cells were preincubated for 1 min with 0.2 mM bicuculline and then perfused with 0.1 mM bicuculline plus
0.5 mM baclofen. In the presence of baclofen and bicuculline the Ba2+ current decreased by 22% in one cell and
by 30% in the second cell (not illustrated). After 2 min of wash out, the Ba2+ current recovered to 97 and 90% of
control in the two cells, respectively. Thus, the effects of baclofen and GABA remained in the presence of the
GABAA receptor antagonist, bicuculline.
2-Hydroxysaclofen, an antagonist of GABAB receptors,[41]was tested in four DSCs. First, the reduction of
Ba2+ current by 0.5 mM GABA was observed, then after a 10 min wash out, 0.1 mM 2-hydroxysaclofen plus
0.5 mM GABA accompanied by 0.1 mM 2-hydroxysaclofen were added to the bath solution. In three cells, the
Ba2+ current remained unchanged (Fig. 4C), while in one cell it increased by 6%.
A second GABAB receptor antagonist, AVA,[59]was also tested. When applied alone, AVA did not modify the
Ba2+ current in a concentration range of 0.14–1.4 mM. To determine the action of AVA on the baclofen effect, six
cells were exposed for 1 min to 0.5 mM AVA. Then they were perfused for 2 min with 0.2 mM AVA plus 0.5 mM
baclofen. In five cells, the Ba2+ currents were not modified (Fig. 4D), while in one cell the Ba2+ current was
decreased by 4%. Thus, the actions of GABA and baclofen on the Ba2+ currents were blocked by GABAB receptor
antagonists.

Fig. 4. Influences of GABA receptor antagonists on the GABA and baclofen reductions of the Ba2+ current. In an
isolated dorsal sensory cell, GABA reduced the Ba2+ current by 13.2% (A). Bicuculline (0.2 mM), a GABAA receptor
antagonist, did not modify the GABA effect in the same cell (B). 2-Hydroxysaclofen (0.1 mM) and AVA (0.2 mM),
GABAB receptor antagonists, blocked the GABA and baclofen reductions of the Ba2+ current in dorsal sensory
cells (C and D, respectively). Controls and tests represent the currents recorded before and after antagonist
application, respectively.
Muscimol (0.5 mM), a GABAA receptor agonist and a weak GABAB agonist,12, 62decreased the peak amplitude of
the Ba2+ current by 13±2.6% (n=8).
Glycine and taurine induced Cl− currents and have been shown to act on both GABA and glycine receptors in
isolated multipolar cells of adult lampreys. The action of glycine (1 mM) and taurine (5 mM) was tested now on
the Ba2+ current in eight DSCs from I. unicuspis and five DSCs from L. fluviatilis. Neither glycine nor taurine
affected the Ba2+ currents.

To measure changes in membrane conductance with application of GABA and baclofen, a passive current was
induced through the membrane in a voltage-clamp mode using depolarizing voltage pulses of 20 mV, 100 ms in
duration, and with intervals of 200 ms for 15 s (Fig. 5). In all eight DSCs tested, the conductance did not change
after application of 0.5–1.0 mM baclofen or 1–4 mM GABA (Fig. 5A,1,2), indicating that neither baclofen nor
GABA activated ligand-gated channels. Consistent with this conclusion, GABA and baclofen application did not
induce any additional currents in the same DSCs (Fig. 5A,4,5). However, it has been shown that activation of
GABAA receptors induces Cl− current and increases the membrane conductance in giant interneurons of the
lamprey spinal cord.[37]To compare GABA and baclofen effects in different populations of lamprey spinal cord
neurons, we performed the same experiments in isolated multipolar neurons (presumably interneurons and/or
motoneurons). As shown in Fig. 5B, baclofen did not produce any membrane conductance change (Fig. 5B2),
while GABA considerably increased the membrane conductance and induced a Cl− current (Fig. 5B1,4).

Fig. 5. Effects of GABA and baclofen on the membrane conductance of spinal neurons. (A) In a dorsal sensory
cell, the amplitudes of passive currents evoked by a series of voltage pulses (3) were not modified by 4 mM
GABA (1) or by 1 mM baclofen (2) applications. Neither GABA nor baclofen induced currents in the same cells in
a voltage-clamp mode (4 and 5, respectively). (B) In a multipolar neuron (presumably an interneuron or a
motoneuron), the amplitudes of passive currents increased after GABA application (1) indicating an increased
membrane conductance, but the current amplitudes were not changed after baclofen application (2). Voltage
pulses in A and B were 20 mV in amplitude and 100 ms in duration (3). GABA, but not baclofen, evoked Cl−
current in the same multipolar neuron (4 and 5, respectively). The moment of drug application is marked by
arrows.

2.2. Morphological investigations
After HRP application to the central stump of the cut dorsal root, the labelled fibers could be followed in
semithin transverse sections for several spinal segments in both the rostral and the caudal directions. Labelled
fibers were found ipsilaterally in the lateral zone of the dorsal column forming a vertically-oriented band
extending from the entrance of the dorsal root to the ventral limit of the dorsal column. Several DSCs were also
labelled. They were characteristically localized in the zone between the dorsal column and the large
reticulospinal Müller axons and they had a rather regular round shape with no dendrites. In transverse ultrathin
sections at the electron microscopic level, the primary afferent fiber profiles labelled with HRP could be easily

distinguished (Fig. 6A,C). After GABA immunocytochemical processing, these fibers never produced any GABAimmunoreactivity (GABA-IR). Labelled primary afferent fibers made conventional synapses onto unidentified
dendrites. These synapses were asymmetric, and contained round synaptic vesicles with a maximum diameter
that ranged from 32 to 61 nm (mean=45.8±6.3 nm, n=150) and with an index of ellipticity of e=0.53.
Postsynaptic dendritic profiles were usually GABA-immunonegative, but some GABA-immunopositive
postsynaptic dendrites were observed. In ultrathin sections obtained from the spinal cords of six animals, we
photographed 62 synapses formed by primary afferent fibers onto postsynaptic dendrites. GABA-ir boutons
containing synaptic vesicles were found in close proximity to 66% of these synapses (Fig. 6). The directly
apposed primary afferent fiber and the GABA-IR bouton profile were not separated by any other profiles. The
apposed GABA-IR boutons often made symmetric synapses onto the same dendritic profile that was contacted
by the primary afferent fiber, thus forming a triad. Synaptic vesicles of the GABA-IR boutons were usually
clustered over the presynaptic membrane, but were also often found to be associated with the membrane
apposed to the afferent fiber. The vesicles of these GABA-IR boutons had a shape and diameter similar to those
observed in the primary afferent fibers. Their maximum diameter ranged from 31 to 55 nm
(mean=46.7±5.6 nm, n=150) and had an index of ellipticity of e=0.56. In most cases the apposition between the
GABA-IR bouton and the afferent axon displayed no synaptic specializations. Only in two cases of these
appositions were observed ultrastructural features that could be interpreted as synaptic-like specializations. In
these cases, small densities were distinguished in the presynaptic and postsynaptic areas of the apposed zones,
and the synaptic vesicles were associated with the presynaptic membranes (Fig. 7).

Fig. 6. Apposition of GABA-immunoreactive boutons and HRP-labelled primary afferent fibers (pa). Two
examples (A and C). (B) High power view of the boxed area in (A). Apposed GABA-immunoreactive boutons are
indicated by asterisks. Appositions are delimited by unfilled arrows. Synapses of primary afferent fibers with

non-identified dendrites (d) are indicated by unfilled arrowheads, and synapses of GABA-immunopositive
boutons with non-identified dendrites are indicated by filled arrowheads.

Fig. 7. Two cases of presumed synaptic-like specializations in the apposed zone of primary afferent fiber (pa) and
GABA-immunoreactive bouton (A, B). GABA-immunoreactive boutons are indicated by asterisks. Appositions are
delimited by unfilled arrows. Filled arrows indicate ultrastructural features which could be interpreted as
synaptic-like specializations. HRP-labelled primary afferent fibers make synapses (unfilled arrowheads) with nonidentified dendrites (d).

3. Discussion
3.1. Physiological investigations
In the present work, we studied the Ca2+ channel currents in DSCs that possessed axonal processes of 40 to
200 μm in length after enzymatic dissociation. While we cannot say with certainty how much the processes
themselves contributed to the results observed here, we suggest that they were likely to be within the voltageclamped zone. In our experiments, the pipette position in different cells varied from the centre of DSC soma to
the initial region of a DSC process, but the effects of GABA agonists on Ca2+ channel currents did not depend on
the micropipette position. This observation supports the idea that the soma and the proximal axonal processes
exhibit similar GABAergic mechanisms and may thus reflect GABAergic mechanisms in more distal axonal
processes. It was shown recently that GABA-immunopositive terminals were located both in close apposition to
the DSC somata and their processes.[8]Therefore, it is quite possible that GABA receptors are distributed both in
the soma and fiber membrane. It seems likely that there are no GABAA receptors in the DSC membrane because
Cl− currents were not induced in DSCs by GABA application.
The Ca2+ channel current was isolated in more than 200 DSCs obtained from two lamprey species, Ichthyomyzon
unicuspis and Lampetra fluviatilis. Judging by the threshold potentials of calcium channel activation in different
DSCs, the calcium channels are not uniform and can be subdivided into several types[9]as in other vertebrate
neurons.42, 48To ensure that all types of Ca2+ channels could be activated, the holding potential was maintained
in our experiments at the level of −100 or −80 mV. Under these conditions, the threshold potentials of
Ca2+ channel currents were close to (−35 mV) or varied between −10 mV and +5 mV. Our results are in
accordance with data on calcium channel properties obtained in DSCs of the isolated lamprey spinal
cord.18, 47Christenson et al.[18]reported that the presence of low-voltage-activated calcium channels is
characteristic of touch-activated DSCs, but not of pressure-activated DSCs of the lamprey spinal cord. They gave
the fraction of low-voltage-activated DSCs as three out of fifteen total DSCs.

In the present study, GABA reduced the peak amplitude of Ca2+ channel currents in isolated DSCs. In the present
investigation, it was also observed that the GABA effect was mimicked by baclofen, a GABAB receptor agonist.
The baclofen effect was reversible and was abolished by GABAB receptor antagonists. Thus, the evidence here
strongly suggests that the GABA and baclofen effect on lamprey DSCs is mediated by GABAB receptors and that it
acts to reduce the peak amplitude of voltage-activated calcium current. This is in accordance with the data
obtained by Matsushima et al.,[47]who found using single-electrode voltage-clamp recordings in the isolated
lamprey spinal cord that baclofen reduced the peak amplitude of calcium currents in both low- and highthreshold Ca2+ channels in motoneurons and interneurons. The involvement of GABAB receptor activation in the
mediation of presynaptic inhibition has been previously demonstrated in the isolated spinal cord of the
lamprey.4, 17These authors demonstrated additionally that these GABAB effects are mediated by G-proteins.
Therefore, taken together, the evidence suggests that GABA-mediated presynaptic inhibition of lamprey DSC
fibers results from GABAB receptor activation followed by a decrease of inward voltage-activated calcium
currents. The inhibition of calcium entrance into the axonal presynaptic zone results in a decrease of
neurotransmitter release in many other preparations.13, 22, 40, 46Therefore, glutamate release from sensory
afferent fiber synapses terminating on spinal interneurons and motoneurons will be decreased.
According to the data obtained in the present work, GABA and baclofen application did not change the
membrane conductance of the DSCs. In addition, GABAA receptor antagonists did not modify the GABA effect on
the DSCs. This lack of GABAA effect in the isolated DSCs (Fig. 5A,4) can not be attributed to the enzyme
treatments used for dissociation because under the same conditions isolated multipolar cells displayed robust
GABAA effects (Fig. 5B,4). It seems likely, therefore, that the DSC membrane possesses no or few
GABAA receptors and that there may be different GABAA and GABAB receptor distributions in different neuron
populations of the lamprey spinal cord.

3.2. Morphological investigations
Six amino acid-protein complexes fixed with glutaraldehyde were used for testing the specificity of the antiGABA antibody. The control experiments showed a selective labelling of GABA-containing conjugate. The other
amino acids expressed no immunogold labelling or only weak labelling in the case of aspartate-containing
conjugate. This allows us to conclude that the antibody detects GABA in the tissue with sufficient selectivity. In
our experimental material, immunolabelling was clustered over profiles containing synaptic vesicles. The
ultrastructure of these synapses differed from that of primary afferent synapses. Synapses made by the
immunolabelled boutons onto unidentified dendrites were symmetric while the primary afferent fibers
established asymmetric synapses which are known to be glutamatergic.[17]Therefore, the ultrastructure of
these GABA-immunolabelled boutons alone suggests that they belong to inhibitory neurons. It has been
proposed that the density of gold particles reflects the antigen concentration.[54]Since the density of gold
particles over the boutons exceeded the background by more than five times, it is concluded that there was a
high concentration of GABA in the immunolabelled boutons.
The arrangement of GABA-IR boutons apposed to HRP-labelled fibers from the dorsal root and located in the
lamprey dorsal column, which was observed in our experiments, coincides on the whole with the descriptions of
Christenson et al.[20]In that work, GABA-IR terminals were found to make appositions with unlabelled axons
located in the dorsal column. These authors concluded that axons with apposed GABA-IR profiles were primary
afferent axons because most of the axons of the dorsal column are probably derived from primary sensory
neurons.19, 57Our findings made with HRP-labelled primary afferent fibers confirm this conclusion.
In few cases, we found ultrastructural features which could be interpreted as synaptic specializations between
the GABA-IR boutons and the primary afferent fibers. This observation is in agreement with the previous finding
that only 2–3% of apposed GABA-IR terminals and GABA-negative axons could be suggested to make a

synapse.[20]It seems unlikely that GABA release in these rare synapses could be sufficient to produce the total
inhibitory effect on the primary afferent axons. Rather the GABA effect on the primary afferent axon is
extrasynaptic. The lack of true axoaxonal synapses in lamprey primary afferent terminal therefore suggests that
GABA is acting extrasynaptically in this model of presynaptic inhibition in lamprey and it is also consistent with
the absence of GABAA receptors in dorsal sensory cells. Stuart and Redman[63]also suggested that in cat primary
afferents, (−)-baclofen-activated receptors are predominantly extrasynaptic.
It is possible to hypothesize that GABA reaches the extrasynaptic GABAB receptors of the primary afferent axon
membrane by two different routes. In the first hypothesized route, GABA could be released non-synaptically
from the apposed bouton, and in the second route, GABA could diffuse from neighbouring axodendritic
synapses of the GABA-IR terminals (Fig. 8). Non-synaptic release of GABA from GABA-containing axon terminals
was proposed by Christenson et al.[20]to be a way of GABA access to the primary afferent fibers in this neuronal
circuit of the lamprey. Non-synaptic release of other neurotransmitters and their actions on distant receptors
has been previously discussed.2, 7, 33The long extent of the appositions and the frequently observed clustering
of synaptic vesicles near the apposed neuronal membrane can be considered as an arrangement favourable to
this mode of GABA action. Under conditions of high sustained activity, it has been shown that the GABAtransporter may function in reverse, thereby increasing extracellular levels of GABA.[56]Carrier-mediated
release of GABA from neurons and glial cells has been demonstrated in different experimental
conditions.27, 44Carrier-mediated release could therefore increase the level of GABA around the primary
afferent fibers in the extrasynaptic zone.

Fig. 8. Schematic drawing of the neuronal circuitry providing presynaptic inhibition of lamprey spinal cord
primary afferents. GABA presumably acts on the extrasynaptic GABAB receptors located on the primary afferent
fiber surface in the apposition zone (a). GABA could reach these receptors by diffusing from neighbouring
synaptic cleft (s) or by being released non-synaptically.
However, there are also arguments in favour of the second hypothesis regarding the route for GABA to reach
extrasynaptic GABAB receptors. The lateral diffusion of transmitter from one discrete postsynaptic domain to
another has been shown in neighbouring glycinergic synapses of the Mauthner cell.[31]In addition, there is
experimental evidence suggesting that during increased synaptic release, only part of the GABA can be removed
by re-uptake. Under these conditions, GABA would diffuse to extrasynaptic sites and act upon extrasynaptic
receptors (for review see [60]). Experimental evidence for distant actions of GABA has been obtained in the
neuronal circuits of the hippocampus.[38]Stimulation of one bundle of afferent fibers in the stratum radiatum
region of CA1 caused short-lasting, heterosynaptic depression of excitatory transmission in an independent,

overlapping set of inputs. These authors concluded that GABA released from conventional synapses spilled over
and acted as a diffuse signal onto nearby (within micrometers) excitatory synaptic terminals. This conclusion was
supported by the observation that inhibition of GABA re-uptake enhanced the presynaptic inhibitory effect of
GABA in this paradigm.[38]Diffusion of GABA from GABAergic synapses to neighbouring glutamate-containing
terminals in the mammalian brain and the subsequent action of GABA on GABAB receptors have already been
discussed.[51]Our data do not contain sufficient evidence permitting exclusion of either hypothesis, but it seems
likely that the ultrastructural interrelations observed in the lamprey spinal cord could provide the morphological
substrate for both mechanisms of GABA actions on the primary afferent fiber: the effect of GABA released nonsynaptically or diffusing from neighbouring conventional synapses.

4. Conclusion
The data concerning the physiological and morphological basis of primary afferent presynaptic inhibition in
lampreys and in mammals do not coincide in all details. It seems likely that in lamprey, presynaptic inhibition of
primary afferents is mediated by GABAB receptors, and GABAA receptors seem to be absent in the lamprey
primary afferent neurons (at least in one class of primary afferents, the dorsal sensory cells). In mammals,
however, primary afferent presynaptic inhibition is mediated by GABAA receptors55, 63, 65or both GABAA and
GABAB receptors.[24]Synaptic contacts of GABA-containing boutons and primary afferent fibers have been
described in mammals,6, 49while in lamprey such synapses are extremely rare if not absent at all
(Christenson et al.[20]and the present investigation). This variance may be explained by species differences. It
can also be suggested that the difference in GABA receptor types observed in primary afferent neurons of
lampreys versus mammals may be due to the fact that we have studied GABA receptors only in the dorsal
sensory cells, which represent only one class of lamprey primary afferent neurons and are not present in
mammals. It has been shown that GABAA receptors mediate presynaptic inhibition in other neurons of the
lamprey spinal cord.[3]
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